A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 21 Mar 2018
At a glance
- Drugs Letrozole (Primary) ; Palbociclib (Primary)
- Indications Early breast cancer
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms PALLET
- 15 Mar 2018 Status changed from recruiting to active, no longer recruiting.
- 15 Mar 2018 Planned End Date changed from 1 May 2018 to 30 Sep 2019.
- 22 Feb 2018 Planned End Date changed from 31 Oct 2017 to 1 May 2018.